BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 37287447)

  • 21. Using serum anti-Müllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis.
    Peigné M; Bernard V; Dijols L; Creux H; Robin G; Hocké C; Grynberg M; Dewailly D; Sonigo C
    Hum Reprod; 2023 Sep; 38(9):1789-1806. PubMed ID: 37475164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
    Alebic MŠ; Stojanovic N; Dewailly D
    Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
    Hamdine O; Eijkemans MJ; Lentjes EW; Torrance HL; Macklon NS; Fauser BC; Broekmans FJ
    Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into ovarian response with a fixed low dose FSH stimulation in an IUI programme: the PRORAILS study.
    Rutten A; van Ballegooijen H; Broekmans F; Cohlen B;
    Hum Reprod; 2022 Jun; 37(7):1440-1450. PubMed ID: 35460412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting the cumulative chance of live birth over multiple complete cycles of in vitro fertilization: an external validation study.
    Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; McLernon DJ; Bhattacharya S; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2018 Sep; 33(9):1684-1695. PubMed ID: 30085143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
    Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eight weeks of androgen priming by daily low-dose hCG injections before ICSI treatment in women with low ovarian reserve.
    Friis Wang N; Bogstad JW; Pors SE; Petersen MR; Pinborg A; Yding Andersen C; Løssl K
    Hum Reprod; 2023 Apr; 38(4):716-725. PubMed ID: 36721920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between vascular health and ovarian ageing in type 1 diabetes mellitus.
    Yarde F; Spiering W; Franx A; Visseren FL; Eijkemans MJ; de Valk HW; Broekmans FJ;
    Hum Reprod; 2016 Jun; 31(6):1354-62. PubMed ID: 27052503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
    Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
    Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study.
    Koedooder R; Singer M; Schoenmakers S; Savelkoul PHM; Morré SA; de Jonge JD; Poort L; Cuypers WJSS; Beckers NGM; Broekmans FJM; Cohlen BJ; den Hartog JE; Fleischer K; Lambalk CB; Smeenk JMJS; Budding AE; Laven JSE
    Hum Reprod; 2019 Jun; 34(6):1042-1054. PubMed ID: 31119299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Could hormonal and follicular rearrangements explain timely menopause in unilaterally oophorectomized women?
    Grynberg M; Labrosse J; Bennani Smires B; Sifer C; Peigne M; Sonigo C
    Hum Reprod; 2021 Jun; 36(7):1941-1947. PubMed ID: 34037751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
    Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
    Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study.
    Depmann M; Eijkemans MJ; Broer SL; Scheffer GJ; van Rooij IA; Laven JS; Broekmans FJ
    Hum Reprod; 2016 Jul; 31(7):1579-87. PubMed ID: 27179263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiopathic early ovarian ageing: risk of miscarriage and chance of delivery following ART in a nationwide cohort study.
    Christensen MW; Ingerslev HJ; Kirkegaard K; Kesmodel US
    Hum Reprod; 2022 Jul; 37(8):1856-1870. PubMed ID: 35522192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.
    Fernández Sánchez M; Višnová H; Larsson P; Yding Andersen C; Filicori M; Blockeel C; Pinborg A; Khalaf Y; Mannaerts B;
    Hum Reprod; 2022 May; 37(6):1161-1174. PubMed ID: 35451013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between ovarian reserve and spontaneous miscarriage and their shared genetic architecture.
    Yi Y; Fu J; Xie S; Zhang Q; Xu B; Wang Y; Wang Y; Li B; Zhao G; Li J; Li Y; Zhao J
    Hum Reprod; 2023 Nov; 38(11):2247-2258. PubMed ID: 37713654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
    Balkenende EME; Dahhan T; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; Smeenk JMJ; Louwé LA; Cantineau AEP; de Bruin JP; Linn SC; van der Veen F; van Wely M; Goddijn M
    Hum Reprod; 2022 Jul; 37(8):1786-1794. PubMed ID: 35776109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.
    Schufreider A; McQueen DB; Lee SM; Allon R; Uhler ML; Davie J; Feinberg EC
    Hum Reprod; 2015 Nov; 30(11):2686-92. PubMed ID: 26345686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.